Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharmaceuticals    save search
EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering
Published: 2023-12-06 (Crawled : 02:00) - globenewswire.com
EYPT 1 d | $17.76 -3.16% -3.27% 7.7M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
offering pharmaceuticals
Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
GOOG | News | $132.45 1.39% 1.37% 19M twitter stocktwits trandingview |
Technology Services
 | Email alert Add to watchlist
GOOGL | News S | $131.03 1.36% 1.34% 27M twitter stocktwits trandingview |
Technology Services
 | Email alert Add to watchlist
GSK | News | $36.33 -0.82% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
NVS | News | $96.97 -2.04% 0.16% 2.8M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
GLAXF | News | $18.4 -1.3% 2.3K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
AZNCF | News | $128.52 5.82% 2.6K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
BAX | News | $35.8 -2.96% -0.84% 3M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
AMGN | News S | $270.88 -0.61% -0.61% 1.7M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
AZN | News | $64.005 -1.56% -1.59% 4M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
ABBV | News | $144.57 0.29% 0.0% 4M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
ADBE | News M | $602.22 -0.39% -0.39% 2.5M twitter stocktwits trandingview |
Technology Services
 | Email alert Add to watchlist
NVSEF | News | $97.95 2.98% 100 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
tube companies abbvie cancer pharmaceuticals therapeutics market
Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor's (rosuvastatin) OTC Switch Technology Provider
Published: 2023-12-05 (Crawled : 16:00) - biospace.com/
PTPI | News | $1.385 1.1% 1.08% 730K twitter stocktwits trandingview |
| Email alert Add to watchlist
cholesterol pharmaceuticals technology
OXFORD PROPERTIES BREAKS GROUND ON 165,000 SQ FT EXPANSION OF IONIS PHARMACEUTICALS CARLSBAD CAMPUS
Published: 2023-12-05 (Crawled : 16:00) - prnewswire.com
IONS | News | $50.02 -2.8% -2.88% 1.6M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
pharmaceuticals expansion
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America's Most Successful Small-Cap Companies
Published: 2023-12-05 (Crawled : 13:00) - globenewswire.com
CPRX | News | $14.25 -5.38% -5.68% 1.5M twitter stocktwits trandingview |
Health Technology
 | | O: 0.54% H: 0.13% C: -3.91%
companies pharmaceuticals
Branded Legacy, Inc. (BLEG) Expands Portfolio with Comprehensive Acquisition of MariJ Pharmaceuticals Inc, Including Licenses, Organic Certifications, and Substantial Assets
Published: 2023-12-05 (Crawled : 12:00) - globenewswire.com
BLEG | News | $0.0035 22.86% 17M twitter stocktwits trandingview |
Manufacturing
 | Email alert Add to watchlist
organic acquisition pharmaceuticals
Vanda Pharmaceuticals Announces that U.S. Food and Drug Administration Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis
Published: 2023-12-04 (Crawled : 23:00) - prnewswire.com
LLY | News 4 d | $588.15 0.42% 0.09% 2M twitter stocktwits trandingview |
Health Technology
 | | O: 0.08% H: 0.0% C: 0.0%
VNDA | $3.96 2.86% 2.78% 610K twitter stocktwits trandingview |
Health Technology
 | | O: 0.13% H: 1.53% C: 0.76%
drug food treatment pharmaceuticals application
Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2023-12-04 (Crawled : 21:00) - globenewswire.com
XENE 1 d | $38.715 2.53% 2.47% 510K twitter stocktwits trandingview |
Health Technology
 | | O: 1.83% H: 2.35% C: 2.19%
offering pharmaceuticals
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
Published: 2023-12-04 (Crawled : 21:00) - globenewswire.com
EYPT 1 d | $17.76 -3.16% -3.27% 7.7M twitter stocktwits trandingview |
Health Technology
 | | O: -12.29% H: 0.0% C: 0.0%
offering pharmaceuticals
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-04 (Crawled : 21:00) - globenewswire.com
XFOR | $0.8853 7.73% 7.17% 5.3M twitter stocktwits trandingview |
Health Technology
 | | O: 15.85% H: 9.39% C: 5.27%
nasdaq pharmaceuticals grants
Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALS
Published: 2023-12-04 (Crawled : 15:30) - biospace.com/
AMLX | $14.85 2.7% 2.63% 1.8M twitter stocktwits trandingview |
| Email alert Add to watchlist
amx0035 neuroinflammatory als publication pharmaceuticals biomarkers
Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions
Published: 2023-12-04 (Crawled : 13:00) - globenewswire.com
HURN S | $105.475 -2.2% -2.25% 130K twitter stocktwits trandingview |
Commercial Services
 | | O: 3.05% H: 0.0% C: 0.0%
CPRX | News | $14.25 -5.38% -5.68% 1.5M twitter stocktwits trandingview |
Health Technology
 | | O: 2.22% H: 0.0% C: 0.0%
AMRN | News | $0.7201 2.29% 2.24% 3M twitter stocktwits trandingview |
Health Technology
 | | O: -1.96% H: 0.0% C: 0.0%
pharmaceuticals financial
EyePoint Pharmaceuticals Announces Positive Topline Data from the Phase 2 DAVIO 2 Trial of EYP-1901 in Wet AMD Achieving All Primary and Secondary Endpoints
Published: 2023-12-04 (Crawled : 12:00) - globenewswire.com
EYPT 1 d | $17.76 -3.16% -3.27% 7.7M twitter stocktwits trandingview |
Health Technology
 | | O: 256.79% H: 0.0% C: 0.0%
eyp-1901 positive pharmaceuticals topline trial
Tonix Pharmaceuticals Announces IND Clearance by the FDA for Phase 2 Trial of TNX-2900 for the Treatment of Prader-Willi Syndrome, the Most Common Genetic Cause of Life-Threatening Childhood Obesity
Published: 2023-12-04 (Crawled : 12:00) - globenewswire.com
TNXP | $0.4799 1.05% 1.04% 1.3M twitter stocktwits trandingview |
Health Technology
 | | O: 4.25% H: 0.0% C: 0.0%
tnx-2900 fda obesity genetic treatment clearance pharmaceuticals trial
Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)
Published: 2023-12-02 (Crawled : 20:20) - globenewswire.com
XENE 1 d | $38.715 2.53% 2.47% 510K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
FNCTF | News | $12.36 -26.03% 1K twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
pipeline pharmaceuticals meeting
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-01 (Crawled : 23:00) - globenewswire.com
ZNTL | $11.65 0.78% 0.77% 430K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
nasdaq pharmaceuticals grants
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-01 (Crawled : 22:00) - globenewswire.com
ORIC | $8.86 4.85% 4.63% 650K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
nasdaq pharmaceuticals grants
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Published: 2023-12-01 (Crawled : 21:00) - prnewswire.com
SNDX | $16.75 0.3% 0.3% 730K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
nasdaq pharmaceuticals grants
Jazz Pharmaceuticals to Present Long-Term and Real-World Data Emphasizing Commitment to Treatment-Resistant Epilepsy at the 2023 American Epilepsy Society Annual Meeting
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
JAZZ | $121.455 0.0% 520K twitter stocktwits trandingview |
Health Technology
 | | O: -0.66% H: 0.0% C: 0.0%
pharmaceuticals meeting
Palvella Therapeutics and Ligand Pharmaceuticals Expand Strategic Partnership to Accelerate Phase 3 Development of QTORIN™ rapamycin for Microcystic Lymphatic Malformations and Additional High Unmet Need Clinical Indications
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
LGND | $59.6 -0.45% -0.45% 160K twitter stocktwits trandingview |
Health Technology
 | | O: 0.36% H: 0.0% C: 0.0%
partnership pharmaceuticals therapeutics
Gainers vs Losers
55% 45%

Top 10 Gainers
ZVSA | $2.03 3179.48% 96.95% 330K twitter stocktwits trandingview |

CHSN | $4.89 68.63% 45.9% 5.7M twitter stocktwits trandingview |

ANY M | $1.72 60.75% 37.79% 26M twitter stocktwits trandingview |
Technology Services
VCXA | News 0 d | $15.88 60.57% 37.72% 82K twitter stocktwits trandingview |

CNET | News | $1.12 60.0% 37.5% 3.8M twitter stocktwits trandingview |
Commercial Services
MFH | $1.62 37.29% 27.16% 6.5M twitter stocktwits trandingview |
Technology Services
AIHS | $0.4389 37.16% 27.09% 230K twitter stocktwits trandingview |
Finance
KALA | $8.83 36.06% 26.5% 2.7M twitter stocktwits trandingview |
Health Technology
JNVR | $1.53 29.66% 21.33% 2.8M twitter stocktwits trandingview |

WHLR 4 | $0.3532 26.14% 20.72% 14M twitter stocktwits trandingview |
Finance
Your saved searches
Save your searches and get alerts when important news are released.